Results from a clinical trial have revealed that Abbott’s HeartMate 3 left ventricular assist device (LVAD) demonstrated superiority over the HeartMate 2 LVAD in the long-term treatment of end-stage heart failure.

Heart pump technology 2019

The results, posted at the 68th American College of Cardiology Scientific Session on 17 March, of the MOMENTUM-3 trial have been cited as promising. Experts say the results demonstrate that further engineering by medical device manufacturers can produce a significant and positive impact on the treatment options for patients with end-stage heart failure.

Abbott’s MagLev pump technology, which is used in the HeartMate 3, is thought to be responsible for the reduction of many severe complications of end-stage heart failure treatment, such as stroke, thrombosis and re-operations for pump replacement.

As such, the device has been established as a clear choice for patients who are unsuitable for heart transplants and who do not respond to other treatments. The rate of stroke was more than 50% lower in the patient pool with the HeartMate 3 after two years. Abbott’s HeartMate 3 LVAD device has also demonstrated reduced hospitalisation time and vastly reduced blood clotting.

These combined findings are an important step toward reducing the costs associated with end-stage heart failure management and will drive the adoption of the implantable HeartMate 3 in developed and developing countries alike.

As newly engineered LVAD devices continue to demonstrate lower risks of complications, re-operations, and hospitalisations, GlobalData expects that the global market for implantable LVADs being used as destination therapies in the treatment of end-stage heart failure will continue to grow over the next decade.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.